Evaluation the sensitivity and specificity of a novel diagnostic kit for the detection of placental alpha-microglobulin-1 (PAMG-1) in the prediction of preterm birth

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

TCTR

Registry ID

TCTR20180703002

Enrollment

Unknown

Registered

2018-07-03

Start date

2018-06-28

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm birth PAMG &#45

Interventions

Follow the patient up until delivery after the results of PAMG&#45

1 retrieving

Screening

PAMG&#45

1 positive and negative

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Preterm labour during gesttaional age about 20-36 weeks of gestation. 2. No leakage of amniotic fluid. 3. cervical opening not greater than 3 cm.

Exclusion criteria

Exclusion criteria: 1. Pregnant women less than 18 years old. 2. Pregnant women with leakage of amniotic fluid or bleeding per vagina 3. Pregnant with previous digital examination.

Design outcomes

Primary

Measure	Time frame
PAMG1 results until delivery Positive and Negative	—

Secondary

Measure	Time frame
Preterm birth until delivery Time of delivery	—

Countries

Thailand

Contacts

Public ContactSaifon Chawanpaiboon

Siriraj Hospital

saifon.cha@mahidol.ac.th0894436106

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026

Evaluation the sensitivity and specificity of a novel diagnostic kit for the detection of placental alpha&#45;microglobulin&#45;1 (PAMG&#45;1) in the prediction of preterm birth